Tech Company Financing Transactions
InpharmD Funding Round
InpharmD, operating out of Northeast Atlanta, secured $6.1 million from 645 Ventures, Atlanta Ventures and SF Capital Group.
Transaction Overview
Company Name
Announced On
12/7/2023
Transaction Type
Venture Equity
Amount
$6,050,000
Round
Seed
Investors
Proceeds Purpose
To make on-demand drug information accessible.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3423 Piedmont Road
Northeast Atlanta, GA 30305
USA
Northeast Atlanta, GA 30305
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Developer of AI-based medical application designed to serve healthcare providers. The company uses pharmacists and artificial intelligence to offer a database of summarized, reputable medical studies, enabling healthcare providers to have better access to health information and hence make better decisions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ashish Advani
Chief Operating Officer
Neil Patel
Browse more venture capital transactions:
Prev: 12/7/2023: ARTBIO venture capital transaction
Next: 12/7/2023: Cortex (CortexEP.com) venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. VC investment data records on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs